European Public Prosecutor's Office

Publications - Reports in relation with the discharge to the Other Institutions - Committee on Budgetary Control

Retrieved on: 
Tuesday, July 25, 2023

Reports in relation with the discharge to the Other Institutions

Key Points: 
  • Reports in relation with the discharge to the Other Institutions
    - 2023/2131(DEC): Reports in relation with the discharge to the European Council and Council
    - 2023/2132(DEC): Reports in relation with the discharge to the Court of Justice of the European Union
    - 2023/2133(DEC): Reports in relation with the discharge to the European Court of Auditors
    - 2023/2134(DEC): Reports in relation with the discharge to the European External Action Service
    - 2023/2135(DEC): Reports in relation with the discharge to the European Economic and Social Committee
    - 2023/2136(DEC): Reports in relation with the discharge to the Committee of the Regions
    - 2023/2137(DEC): Reports in relation with the discharge to the European Ombudsman
    - 2023/2138(DEC): Reports in relation with the discharge to the European Data Protection Supervisor
    - 2023/2139(DEC): Reports in relation with the discharge to the European Public Prosecutor's Office (the 'EPPO')

Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform

Retrieved on: 
Wednesday, June 28, 2023

(Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has been awarded a group of US and European patents related to several additional therapeutic targets for its NaviCap™ targeted oral delivery platform under development.

Key Points: 
  • (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has been awarded a group of US and European patents related to several additional therapeutic targets for its NaviCap™ targeted oral delivery platform under development.
  • EP3554539B1 entitled “Treatment of a disease of the gastrointestinal tract with an integrin inhibitor,” European Patent No.
  • EP3554485B1 entitled “Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices,” European Patent No.
  • These patents are part of Biora’s larger corporate portfolio consisting of 73 patent families, including approximately 180 issued patents and 145 pending applications.

WIPO Publishes Aquavit's Methods for Delivering Bioactive Compositions and Formulations to the Skin

Retrieved on: 
Thursday, March 23, 2023

"Our invention can fulfill an urgent need for a new drug delivery system with higher efficacy and maximized therapeutic benefits.

Key Points: 
  • "Our invention can fulfill an urgent need for a new drug delivery system with higher efficacy and maximized therapeutic benefits.
  • The potential is limitless in using our repeated motion microchannel technology for delivering drugs and biologics."
  • In medical aesthetics, the technology can help achieve optimal skin health and quality, addressing the fundamentals instead of temporary superficial results.
  • The technology can be translated well into delivering drugs and biologics for skin cancer, immunology and dermatological conditions.

Highlights - Presentation of EPPO Annual Report - Committee on Budgetary Control

Retrieved on: 
Saturday, March 18, 2023

Presentation of EPPO Annual Report

Key Points: 
  • Presentation of EPPO Annual Report
    17-03-2023 - 12:31
    On 23 March from 9.00 to 10.30, the LIBE and CONT committees will welcome Laura Codruța Kövesi, the European Chief Prosecutor, to exchange on the latest developments in the activity of the European Public Prosecutor's Office (EPPO) and the annual report 2022 published at the beginning of March.
  • The annual report makes an overview of the activities of EPPO during the last year focusing on EU fraud affecting public revenue, in particular cross-border VAT fraud.

Highlights - Vote on 2021 Discharge: European Commission, EDF, Agencies - Committee on Budgetary Control

Retrieved on: 
Saturday, March 18, 2023

Vote on 2021 Discharge: European Commission, EDF, Agencies

Key Points: 
  • Vote on 2021 Discharge: European Commission, EDF, Agencies
    17-03-2023 - 12:32
    On 22 March 2023, the Members of the Committee for Budgetary Control will vote on the draft reports and amendments concerning the 2021 Discharge to the European Commission, European Development Fund (EDF), and Agencies.
  • The vote is the second batch for the 2021 discharge, after votes on the discharge for the Parliament, other Institutions and the Joint Undertakings on 28 February 2023.
  • The discharge procedure has proven to be a powerful tool to oversee the spending of EU money.
  • Novelties this year are the first discharge for the European Public Prosecutors Office and the European Labour Authority and the inclusion of the Recovery and Resilience Facility in the Commission discharge.

Highlights - Vote on 2021 Discharge: European Parliament, Other Institutions, Joint Undertakings - Committee on Budgetary Control

Retrieved on: 
Sunday, February 26, 2023

Vote on 2021 Discharge: European Parliament, Other Institutions, Joint Undertakings

Key Points: 
  • Vote on 2021 Discharge: European Parliament, Other Institutions, Joint Undertakings
    24-02-2023 - 11:14
    On 28 February 2023, CONT Members will vote on the draft reports and amendments concerning the 2021 Discharge to European Parliament, Other Institutions and Joint Undertakings.
  • CONT Members will vote on the draft reports and amendments concerning the 2021 Discharge to European Parliament, Other Institutions (European Council and Council, European External Action Service, European Court of Justice, European Court of Auditors, European Economic and Social Committee, Committee of the Regions, European Ombudsman, European Data Protection Supervisor, European Public Prosecutor's Office) and Joint Undertakings (F4E, EuroHPC, IHI, Clean Hydrogen, Clean Aviation, CBE, KDT, SESAR, EU-Rail).
  • Recent years have shown a trend towards a greater focus on results and performance, strongly supported and promoted by the European Parliament.
  • Recent years have shown a trend towards a greater focus on results and performance, strongly supported and promoted by the European Parliament.

Press release - Corruption allegations: MEPs push for ambitious changes and quick progress

Retrieved on: 
Monday, February 20, 2023

=* *No more delays for the independent ethics body

Key Points: 


=

  • * *No more delays for the independent ethics body
    Parliament reiterates its call for an independent ethics body for the EU institutions, based on MEPs’ proposals of September 2021, to restore citizens’ trust.
  • The Commission’s proposal should be submitted by March, and negotiations should conclude by the summer break, MEPs say.
  • This body should clearly distinguish between criminal actions, breaches of institutional rules, and unethical behaviour.

Latest news - Next meeting of the FISC Subcommittee - Subcommittee on Tax Matters

Retrieved on: 
Monday, February 20, 2023

Next meeting of the FISC Subcommittee

Key Points: 
  • Next meeting of the FISC Subcommittee
    16-02-2023 - 17:20
    The next meeting of the FISC Subcommittee will take place on 28 March 2023.
  • From 15:00 to 16:00, FISC Members will exchange views with the OECD on the implementation of Pillar 1 and 2 of the OECD's global tax reform.
  • From 16:00 to 17:30, the FISC Subcommittee will host a public hearing on "Case studies on member states national tax policies - Germany: implemented national tax reforms and the combat against aggressive tax schemes".
  • From 17:30 to 18:45, FISC Members will exchange views the European Public Prosecutor's Office on the "Enhancement of the available tools in the fight against VAT Fraud".